Skip to main content
. 2019 Sep 20;14(4):459–467. doi: 10.5009/gnl19107

Table 1.

Demographics and Disease Characteristics of the Study Cohort

Characteristics No. Category Value
Age (yr) at diagnosis 355 37.6±15.2
Sex 355 Male/female 210 (59.2)/145 (40.8)
Body mass index (kg/m2) 344 22.4±3.2
Smoking 342 Never or former 312 (91.2)
Current 30 (8.8)
Alcohol 345 Never or past 191 (55.3)
Current 154(44.6)
Currently employed 348 Yes/no 169 (48.6)/179 (51.4)
Family income* 309 Low (<200) 83 (26.9)
Middle (≥200 and <400) 139 (45.0)
High (≥400) 87 (28.2)
Family history of IBD 334 UC/CD/others 12 (3.6)/1 (0.3)/3 (0.9)
Symptoms duration 354 15.9±36.1
<4 wk 142 (40.1)
≥4 wk 212 (59.9)
Total Mayo score 355 8.1±1.6
Disease severity 355 Moderate/severe 330 (93.0)/25 (7.0)
Endoscopic severity§ 355 Moderate/severe 255 (71.8)/100 (28.2)
Disease extentII 349 Proctitis 35 (10.0)
Left-sided colitis 162 (46.4)
Extensive colitis 152 (43.6)
ESR, mm/hr 304 20.8±19.3
C-reactive protein, mg/dL 324 2.6±7.3
White cell count, 103/μL 346 12.7±60.2
Hemoglobin, g/dL 347 12.8±2.0
Albumin, g/dL 304 4.0±0.6

Data are presented as the mean±SD or number (%).

IBD, inflammatory bowel disease; UC, ulcerative colitis; CD, Crohn’s disease; ESR, erythrocyte sedimentation rate.

*

10,000 Korean Won; Time between the first development of disease-related symptoms and UC diagnosis; Moderate: total Mayo score 6–10; severe: total Mayo score ≥11; §Moderate: Mayo endoscopic subscore=2; severe: Mayo endoscopic subscore=3; IIMontreal classification.